Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 15, 2015 - Issue 2
Submit an article Journal homepage
701
Views
25
CrossRef citations to date
0
Altmetric
SPECIAL FOCUS: In Vitro Companion Diagnostics - Review

Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist

Brett DobleCentre for Health Economics, Faculty of Business and Economics, Monash University, Room 278, Level 2, Building 75 Monash University, Clayton, Victoria 3800, AustraliaCorrespondence[email protected]
,
Marcus TanCentre for Health Economics, Faculty of Business and Economics, Monash University, Room 278, Level 2, Building 75 Monash University, Clayton, Victoria 3800, Australia;Deakin Health Economics, Deakin Strategic Research Centre – Population Health, Faculty of Health, Deakin University, 221 Burwood Hwy, Burwood, Victoria 3125, Australia
,
Anthony HarrisCentre for Health Economics, Faculty of Business and Economics, Monash University, Room 278, Level 2, Building 75 Monash University, Clayton, Victoria 3800, Australia
&
Paula LorgellyCentre for Health Economics, Faculty of Business and Economics, Monash University, Room 278, Level 2, Building 75 Monash University, Clayton, Victoria 3800, Australia
Pages 235-254 | Published online: 21 Aug 2014

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Vladica M. Veličković, Ursula Rochau, Annette Conrads-Frank, Frank Kee, Stefan Blankenberg & Uwe Siebert. (2018) Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 619-640.
Read now
Joseph D. Khoury. (2016) The evolving potential of companion diagnostics. Scandinavian Journal of Clinical and Laboratory Investigation 76:sup245, pages S22-S25.
Read now
Brett Doble. (2016) Budget impact and cost-effectiveness: can we afford precision medicine in oncology?. Scandinavian Journal of Clinical and Laboratory Investigation 76:sup245, pages S6-S11.
Read now
David Huckle. (2015) The impact of new trends in POCTs for companion diagnostics, non-invasive testing and molecular diagnostics. Expert Review of Molecular Diagnostics 15:6, pages 815-827.
Read now
Jan Trøst Jørgensen. (2015) Companion diagnostics: the key to personalized medicine. Expert Review of Molecular Diagnostics 15:2, pages 153-156.
Read now

Articles from other publishers (20)

Melissa Gomez Montero, Houcine El Alili, Mahmoud Hashim, Peter Wigfield, Mariya Dimova, Ralph Riley & Katie Pascoe. (2022) How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments. PharmacoEconomics - Open 6:5, pages 637-646.
Crossref
Amy J Davidoff, Kaitlin Akif & Michael T Halpern. (2022) Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature. JNCI Monographs 2022:59, pages 12-20.
Crossref
Vivek S Chaudhari, Kanchan C Hole & Amalia M Issa. (2022) Evaluating the quality of the economic evidence in colorectal cancer genomics studies. Personalized Medicine 19:4, pages 361-375.
Crossref
Mikyung Kelly Seo & John Cairns. (2021) How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review. BMC Cancer 21:1.
Crossref
Simon van der Pol, Paula Rojas Garcia, Fernando Antoñanzas Villar, Maarten J. Postma & Antoinette D. I. van Asselt. (2021) Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting. PharmacoEconomics 39:12, pages 1355-1363.
Crossref
Dominik Hartl, Valeria de Luca, Anna Kostikova, Jason Laramie, Scott Kennedy, Enrico Ferrero, Richard Siegel, Martin Fink, Sohail Ahmed, John Millholland, Alexander Schuhmacher, Markus Hinder, Luca Piali & Adrian Roth. (2021) Translational precision medicine: an industry perspective. Journal of Translational Medicine 19:1.
Crossref
Yingping Cao & Xianjin Zhu. 2021. Clinical Molecular Diagnostics. Clinical Molecular Diagnostics 115 120 .
Louisa G. Gordon, Nicole M. White, Thomas M. Elliott, Katia Nones, Anthony G. Beckhouse, Astrid J. Rodriguez-Acevedo, Penelope M. Webb, Xing J. Lee, Nicholas Graves & Deborah J. Schofield. (2020) Estimating the costs of genomic sequencing in cancer control. BMC Health Services Research 20:1.
Crossref
Laurenz Govaerts, Anouk Waeytens, Walter Van Dyck, Steven Simoens & Isabelle Huys. (2020) Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisions. International Journal of Technology Assessment in Health Care 36:4, pages 410-417.
Crossref
Tamlyn Rautenberg, Annette Gerritsen & Martin Downes. (2020) Health Economic Decision Tree Models of Diagnostics for Dummies: A Pictorial Primer. Diagnostics 10:3, pages 158.
Crossref
Barbara S. Ducatman, Alan M. Ducatman, James M. Crawford, Michael Laposata & Fred Sanfilippo. (2020) The Value Proposition for Pathologists: A Population Health Approach. Academic Pathology 7, pages 2374289519898857.
Crossref
Yaling Yang, Lucy Abel, James Buchanan, Thomas Fanshawe & Bethany Shinkins. (2018) Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK. PharmacoEconomics - Open 3:3, pages 281-291.
Crossref
Elisabeth G. E. de Vries, Laura Kist de Ruijter, Marjolijn N. Lub-de Hooge, Rudi A. Dierckx, Sjoerd G. Elias & Sjoukje F. Oosting. (2018) Integrating molecular nuclear imaging in clinical research to improve anticancer therapy. Nature Reviews Clinical Oncology 16:4, pages 241-255.
Crossref
Edward Meinert, Abrar Alturkistani, Dee Luo, Kimberley Foley, Ching Lam, Alison Carter, Donna Seyfried, Josip Car & David Brindley. 2019. Companion and Complementary Diagnostics. Companion and Complementary Diagnostics 455 472 .
Brett Doble. 2019. Companion and Complementary Diagnostics. Companion and Complementary Diagnostics 381 398 .
Annamaria Guglielmo, Nicoletta Staropoli, Monica Giancotti & Marianna Mauro. (2018) Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations. Cost Effectiveness and Resource Allocation 16:1.
Crossref
Peter J Selby, Rosamonde E Banks, Walter Gregory, Jenny Hewison, William Rosenberg, Douglas G Altman, Jonathan J Deeks, Christopher McCabe, Julie Parkes, Catharine Sturgeon, Douglas Thompson, Maureen Twiddy, Janine Bestall, Joan Bedlington, Tilly Hale, Jacqueline Dinnes, Marc Jones, Andrew Lewington, Michael P Messenger, Vicky Napp, Alice Sitch, Sudeep Tanwar, Naveen S Vasudev, Paul Baxter, Sue Bell, David A Cairns, Nicola Calder, Neil Corrigan, Francesco Del Galdo, Peter Heudtlass, Nick Hornigold, Claire Hulme, Michelle Hutchinson, Carys Lippiatt, Tobias Livingstone, Roberta Longo, Matthew Potton, Stephanie Roberts, Sheryl Sim, Sebastian Trainor, Matthew Welberry Smith, James Neuberger, Douglas Thorburn, Paul Richardson, John Christie, Neil Sheerin, William McKane, Paul Gibbs, Anusha Edwards, Naeem Soomro, Adebanji Adeyoju, Grant D Stewart & David Hrouda. (2018) Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Programme Grants for Applied Research 6:3, pages 1-528.
Crossref
Thomas Efferth, Mohamed E.M. Saeed, Elhaj Mirghani, Awadh Alim, Zahir Yassin, Elfatih Saeed, Hassan E. Khalid & Salah Daak. (2017) Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget 8:30, pages 50284-50304.
Crossref
Brett Doble, Thomas John, David Thomas, Andrew Fellowes, Stephen Fox & Paula Lorgelly. (2017) Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing. Lung Cancer 107, pages 22-35.
Crossref
M. Verma. 2017. Progress and Challenges in Precision Medicine. Progress and Challenges in Precision Medicine 115 128 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.